SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-19-007204
Filing Date
2019-02-13
Accepted
2019-02-13 16:25:43
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES X, L.P.ATLAS VENTURE ASSOCIATES X, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv513454_sc13g.htm SC 13G 76672
  Complete submission text file 0001144204-19-007204.txt   78251
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund X, L.P. (Filed by) CIK: 0001628098 (see all company filings)

IRS No.: 472435989 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Subject) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-90574 | Film No.: 19597590
SIC: 2836 Biological Products, (No Diagnostic Substances)